SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

Canaccord Genuity Maintains Buy on Neurocrine Biosciences, Raises Price Target to $123

Canaccord Genuity maintains Neurocrine Biosciences (NASDAQ:NBIX) with a Buy and raises the price target from $122 to $123.

Benzinga · 05/07/2020 17:52

Canaccord Genuity maintains Neurocrine Biosciences (NASDAQ:NBIX) with a Buy and raises the price target from $122 to $123.